ORX:STO
Orexo AB
SEK 0.98
arrow_downward
-1.70%(-0.017) 1D
Nov 20, 5:29:34 PM GMT+1 · SEK
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ORX...
Open
SEK 1.05
High
SEK 1.05
Low
SEK 0.93
Mkt. cap
345.30M
Avg. vol.
785.30K
Volume
286.21K
P/E ratio
0.07
52-wk high
SEK 22.55
52-wk low
SEK 0.80
EPS
SEK 13.61
Shares outstanding
35.13M
No. of employees
55
Open
SEK 1.05
High
SEK 1.05
Low
SEK 0.93
Mkt. cap
345.30M
Avg. vol.
785.30K
Volume
286.21K
P/E ratio
0.07
52-wk high
SEK 22.55
52-wk low
SEK 0.80
EPS
SEK 13.61
Shares outstanding
35.13M
No. of employees
55
News stories
From web sources and news partners
Nacionale
·
1 hour ago
Will the S&P 500 end 2026 down for the year? It's about 65 points above zero with 27 trading days left
Honolulu Star-Advertiser
·
7 hours ago
Wall Street rout pushes S&P 500, Dow into correction
WXXV News 25
·
1 hour ago
S&P 500 sinks 3.7% and Nasdaq composite goes negative for the year as tech sell-off worsens
FXStreet
·
8 hours ago
Dow Jones Industrial Average drops for a fifth day as AI rout widens
Profile
Orexo is a Swedish pharmaceutical company that develops improved pharmaceuticals based on innovative formulation technologies that meet large medical needs. Through presence its in the US market, drugs and digital therapies are commercialized to treat opioid use disorder and adjacent diseases. Products targeting other therapeutic areas are developed and commercialized worldwide with partners. Wikipedia
About Orexo AB
CEONikolaj Sørensen
Employees55
Founded1995
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Websiteorexo.com